chang recommend
upgrad outperform
upgrad outperform reason
news earn acceler pbm save strateg
execut upsid potenti new ceo time
opportun given group pullback upsid lever
like visibl differenti near term
see healthcar outlook webinar et
save launch pbm partnership
least commit
drop bottom line full transit come
view focu move beyond group-wid tailwind
earli result prep alreadi well underway
view potenti hiccup
time issu ramp off-set upsid potenti
on-going benefit year
strateg plan becom clearer also expect
visibl execut improv antm long-
term strategi servic vertic integr
march investor day blue tradit unit cost advantag
challeng new payment model also
opportun provid servic new provid
model blue partner under-invest
polici overhang earn visibl biggest risk
valuat volatil polici nois around
lawsuit ep hix/medicaid expans
valuat pt ep estim
lt histor averag current forward multipl
support step growth
acceler
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
million except per share data
sg expens oper revenu
percentag chang share outstand dilut
net provid oper activ
goodwil intang asset
day medic claim payabl
return invest capit
return invest tangibl capit
evercor isi project januari
valuat methodolog base mix discount cash flow analysi rel valuat multipl
risk valuat includ regulatori risk overal market risk well unforeseen event relat individu cover
compani broader sector includ new competit product technolog
articl articl
time dissemin januari
analyst michael newshel matthew nicolai primarili respons prepar research report attest follow
view opinion render research report reflect person view subject compani issuer
part research analyst compens directli relat specif recommend view research report
